Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
Stakeholder Letter to CMS Regarding Reporting of Home Address for Telehealth Practitioners
-
ACMG Comments on CMS Proposed Rule for CY 2025 PFS and Other Medicare Changes
-
Stakeholder Letter Supporting Joint Resolutions to Overturn FDA Rule on LDTs
-
ACMG Response to Senate HELP Committee RFI on Diagnostics Regulation
-
Sign-on Letter Asking Congress to Make Medicare Telehealth Waivers Permanent
-
Sign-on Letter to Congress Urging Reversal of 2024 Physician Payment Cuts
-
ACMG Comments on FDA Proposed Rule for Regulation of LDTs
-
Sign-on Letter Asking Congress to Pass Legislation to Stop Pending Physician Payment Cuts
-
Stakeholder Letter Asking Congress Renew Efforts on CLIA Reform and Urge FDA to Halt LDT Rulemaking
-
Letter to FDA Requesting Extension of Comment Period for Proposed Rule on Regulation of LDTs